University HealthCare Alliance

November 10, 2020

Stanford University 2nd Annual Spinal Muscular Atrophy Symposium | Dec 3-5, 2020

Best Practices for SMA in an Evolving Treatment Era: Advantages & Challenges of Multidisciplinary Care

Building on the success of our first spinal muscular atrophy (SMA) continuing medical education conference in 2019, the education and training of the healthcare community continues.  In this era of disease-specific treatments for individuals with SMA, the options for multidisciplinary medical and rehabilitative management are continuing to expand. 

Optimal management and treatment recommendations are evolving while ethical considerations are weighed to treat and manage patients with SMA effectively.  The goal of the course is to enhance the understanding of medical and rehabilitative management of SMA for healthcare providers who practice within or outside specialized centers, including physicians; advanced care providers; physical, occupational, and speech therapists; nurses; social workers, or other complex care team members. 

As more individuals with SMA are being diagnosed earlier, treated more effectively, and living longer lives, community providers are increasingly engaged with this population and the groundbreaking therapeutics that are revolutionizing their care. Furthermore, novel treatments will soon require similar care consideration for many other neuromuscular disorders.


$25 discount for UHA affiliates. Use code “SMA25”.


  • Thursday, December 3, 2020: 8:30 AM to 11:30AM Pacific (11:30AM-2:30PM Eastern; 5:30PM- 8:30PM Central European)
  • Friday, December 4, 2020: 8:30 AM to 11:05 AM Pacific (11:30AM-2:05PM Eastern; 5:30PM- 8:05PM Central European)
  • Saturday, December 5, 2020:  8:30 AM to 11:30AM Pacific (11:30AM-2:30PM Eastern; 5:30PM- 8:30PM Central European)


  • Overview of SMA multidisciplinary medical management
  • The implications of newborn screening
  • Ethical considerations in the treatment and management of SMA
  • In-depth discussions of rehabilitation of evolving SMA phenotypes across the lifespan


This conference brings together world-renowned experts in the field of spinal muscular atrophy. Don’t miss your opportunity to network with and learn from over 30 faculty at the front of SMA care and research including:

Bakri Elsheikh, MD
Associate Professor – Clinical, Department of Neurology
Ohio State University

Richard S Finkel, MD
Director of Translational Neuroscience Research
St. Jude Children’s Research Hospital

Eugenio Mercuri, MD, PhD
Professor of Pediatric Neurology
Catholic University

Alyssa Burgart, MD
Co-Chair of the Ethics Committee, Lucile Packard Children’s Hospital
Clinical Assistant Professor, Anesthesiology, Perioperative and Pain Medicine, Stanford University


The Stanford University School of Medicine is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

Stanford Health Care Department of Rehabilitation is an approved provider for physical therapy, occupational therapy, and speech language pathology for courses that meet the requirements set forth by the respective Boards.

Credit Designation
The Stanford University School of Medicine designates this Live Activity for a maximum of 9.50 AMA PRA Category 1 CreditsTM.  Physicians should claim only the credit commensurate with the extent of their participation in the activity.

The California Board of Registered Nursing recognizes that Continuing Medical Education (CME) is acceptable for meeting RN continuing education requirements as long as the course is certified for AMA PRA Category 1 CreditsTM (  Nurses will receive a Certificate of Participation following this activity that may be used for license renewal.

This course is approved for SLP, PT and OT 9.50 credits for completion of entirety of course.